Atossa Genetics Inc. | Mutual Funds
Mutual Funds that own Atossa Genetics Inc.
Vanguard Extended Market Index Fund
33,864
0.67%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
13,949
0.28%
0
0%
07/31/2018
Fidelity Nasdaq Composite Index
1,820
0.04%
0
0%
07/31/2018
1,260
0.03%
0
0.01%
09/05/2018
Aviva Investors Investment Funds ICVC - Intl. Ind. Trk. Fd.
210
0%
2
0%
10/15/2017
iShares Core S&P Total US Stock Market ETF
54
0%
0
0%
09/06/2018
| Address |
107 Spring Street
Seattle Washington 98104
United States
|
|
Employees
|
- |
| Website |
http://www.atossagenetics.com |
| Updated |
07/08/2019 |
| Atossa Genetics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests. The ForeCYTE Breast Health Test provides personalized information about the 10-year and lifetime risk of breast cancer for women between ages 18 and 65. |
